ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
DiagnosesAcute Myeloblastic Leukemia

Acute Myeloblastic Leukemia

ICD-10 Coding for Acute Myeloblastic Leukemia(C92.00, C92.01, C92.02)

PRIMARY SPECIALTYOncology
COMPLEXITYHigh
LAST UPDATED09/15/2025
Sam Tuffun, PT, DPT
Physical Therapist | Medical Coding & Billing Contributor

Diagnosis Overview

What is Acute Myeloblastic Leukemia?
Essential facts and insights about Acute Myeloblastic Leukemia

Key Clinical Considerations:

  • Presence of myeloblasts in the bone marrow and peripheral blood
  • Laboratory findings showing elevated white blood cell count with myeloblasts
  • Physical examination may reveal splenomegaly or lymphadenopathy
  • Cytogenetic analysis may show specific chromosomal abnormalities such as translocations
  • Severity criteria include the percentage of blasts in the bone marrow and peripheral blood

Clinical Information

Clinical Criteria & Documentation Requirements

  • Complete blood count (CBC) results must be documented
  • Specific terminology such as 'acute myeloblastic leukemia' must be used
  • Documentation examples include 'Patient presents with elevated myeloblasts and anemia'
  • Medical necessity must be established through clinical findings and treatment plans
  • Quality measures include documentation of treatment response and follow-up care

Coding Guidelines

Usage Guidelines & Examples

  • Use C92.00 for acute myeloblastic leukemia, not otherwise specified, when no further specification is available
  • Do not use this code for chronic myeloid leukemia or other leukemias
  • C92.01 and C92.02 are used for acute myeloblastic leukemia with specific genetic abnormalities
  • Common coding errors include misclassifying acute myeloblastic leukemia as chronic
  • In complex cases, ensure to document all relevant clinical findings to support code selection

Code Exclusions

Important Exclusions

  • Chronic myeloid leukemia (C92.1) is explicitly excluded
  • Use C92.1 for chronic conditions instead of acute
  • Conditions are excluded based on distinct pathophysiology and treatment protocols
  • Common exclusion mistakes include misclassifying acute cases as chronic
  • Related but distinct conditions include acute lymphoblastic leukemia (C91.0)

Related ICD-10 Codes

Primary Codes
C92.00
Acute myeloblastic leukemia, not otherwise specified
C92.01
Acute myeloblastic leukemia with recurrent genetic abnormalities
C92.02
Acute myeloblastic leukemia with other specified genetic abnormalities
Ancillary Codes
D59.1
Differential Codes
C92.50
C92.02
C92.01

Related CPT Codes

CPT codes will be available in a future update.

Specialty Focus

Primary Specialty

Oncology

Specialty Applications

  • Patients diagnosed with acute myeloblastic leukemia
  • Typically affects adults but can occur in children
  • Clinical settings include inpatient oncology units and outpatient hematology clinics
  • Oncology specialty-specific applications for treatment and management
  • Used in treatment contexts such as chemotherapy and stem cell transplantation

Coding Complexity

High Complexity

This diagnosis requires careful attention to:

  • Comprehensive clinical documentation
  • Accurate code selection based on clinical criteria
  • Proper exclusion considerations
  • Specialty-specific coding guidelines

Documentation

Documentation Templates

Template 1

Template: 'Patient diagnosed with acute myeloblastic leukemia based on CBC findings and bone marrow biopsy.'

Template 2

Template: 'Clinical presentation consistent with acute myeloblastic leukemia including fatigue and bleeding.'

Template 3

Template: 'Diagnostic criteria met as evidenced by 30% myeloblasts in bone marrow.'

Template 4

Template: 'Treatment plan initiated for acute myeloblastic leukemia with chemotherapy regimen.'

Template 5

Template: 'Follow-up care for acute myeloblastic leukemia including monitoring of blood counts and response to treatment.'

Billing Information

Billing Considerations

  • Ensure proper documentation for billing
  • Verify code specificity requirements
  • Check for any additional codes needed
  • Review payer-specific guidelines

Common Issues

  • Insufficient clinical documentation
  • Incorrect code selection
  • Missing supporting diagnoses
  • Timing and frequency documentation

Frequently Asked Questions

What documentation is required for this diagnosis?

Documentation must include clinical findings, lab results, and treatment plans.

How does this differ from similar diagnoses?

Acute myeloblastic leukemia is characterized by myeloblast proliferation, unlike lymphoblastic leukemia.

What are common billing considerations?

Ensure accurate coding to reflect the specific type of leukemia for optimal reimbursement.

What procedures are typically associated?

Common procedures include bone marrow biopsy and cytogenetic testing.

Are there any quality reporting implications?

Quality measures may include treatment response rates and follow-up care documentation.